Diuron, a substituted urea herbicide, is carcinogenic to the rat urinary bladder at high dietary levels (2500 ppm). To further elucidate the mode of action, this study aimed to determine the time course and sequence of bladder cytotoxic and proliferative changes induced by diuron treatment of male Wistar rats. Rats were randomized into two groups (control and 2500 ppm diuron) and treated for 28 days. Ten rats from each group were termi nated on each of study days 1, 3, 7, or 28. Scanning electron micro scopy (SEM) showed urothelial cell swelling beginning on day 1, and by day 28, showed extensive necrosis, exfoliation and piling up of cells suggestive of hyperplasia. No difference in the bromo deoxyuridine labeling index was detected. In a second experiment, rats were randomized into control and diurontreated groups and treated for 7 days or 8 weeks. After 7 days, transmission electron microscopy showed cell degenerative changes and distention of the cytoplasm, organelles, and nuclei characteristic of cytolysis. This resulted in protrusion of the superficial cells into the lumen, corresponding to the cell swelling observed previously by SEM. After 8 weeks, bladders in the diurontreated group showed an increased incidence of simple hyperplasia by light microscopy (6/10, p < 0.05) compared with controls (0/10) and a significantly different SEM classification. In summary, our results support the hypothesis that urothelial cytotoxicity followed by regenerative cell proliferation are the sequential key events that occur with highdose diuron exposure in rats.
Pesticide expenditures totaled more than 39.4 billion dollars in 2007 and the amount used exceeded 5.2 billion pounds worldwide, with herbicides responsible for the largest portion (United States Environmental Protection Agency [USEPA], 2011). The potential toxicity of agricultural pesticides to human health is an important public health issue.
Diuron (3-[3,4-dichlorophenyl] -1,1-dimethylurea) is a substituted urea compound registered as a pre-and postemergent herbicide selective for broadleaf weeds and some annual grasses that can be used alone or in combination with other herbicides. Reported use is on industrial sites, on rights-of-way, around farm buildings, and on irrigation and drainage ditches for general weed control. It is also used with many crops, such as soybeans, cotton, citrus fruits, sugar cane, alfalfa, wheat, grapes, pineapple, cocoa, and coffee. Furthermore, diuron can be used as a mildewcide in plants and stain preventative and as an algaecide in commercial fish production (Australian Pesticides and Veterinary Medicine Authority [APVMA], 2005; USEPA, 2003) .
In a 2-year bioassay, continuous dietary exposure to diuron at 2500 ppm was carcinogenic to rats, with an increased incidence of urinary bladder papillomas and carcinomas in both genders of Wistar rats and a renal pelvis papilloma and two carcinomas in male Wistar rats (APVMA, 2011) . There was also a marginal (equivocal) increase in mammary gland adenocarcinomas in female NMRI mice (APVMA, 2011) at the same dietary concentration. One study reported that dietary exposure of male Wistar rats to 2500 ppm diuron after 4 weeks led to increases of urothelial hyperplasia (APVMA, 2011) . Likewise, 20 weeks of dietary exposure to 2500 ppm diuron in male Wistar rats induced increased urothelial cell proliferation, demonstrated by increased proliferating cell nuclear antigen (PCNA) labeling index and simple hyperplasia of the urothelium by light microscopy (Nascimento et al., 2006) , conditions considered to predispose rats to neoplasia in the urinary bladder mucosa (Cohen, 1998) . In addition, scanning electron microscopy (SEM) evaluation showed urinary bladder mucosal necrosis by 15 and 30 weeks after diuron administration (Da Rocha et al., 2010) . Based on these data, cytotoxicity with consequent regenerative hyperplasia of the urothelium has been proposed as the mode of action (MOA) for diuron-induced rat urothelial carcinogenesis. However, whether cytotoxicity actually occurs prior to increased proliferation has not been reported.
Urothelial cytotoxicity can be induced by either the presence of abnormal urinary solids or the toxicity of the parent chemical and/or its metabolites excreted in the urine. Analysis of urinary sediment from control and 2500 ppm diuron-fed animals revealed that both groups had urinary crystals. In the urine of the 2500 ppm diuron-exposed group, the crystals were compact and accompanied by a greater quantity of amorphous precipitate (Nascimento et al., 2006) . In a subsequent study, coadministration of 2500 ppm diuron and 10,000 ppm NH 4 Cl in the diet decreased urinary pH resulting in a marked reduction of crystals and precipitate in the urine of diuron-treated animals. However, there was no apparent effect on the incidence and/or severity of the urothelial lesions induced by diuron, indicating that urothelial cytotoxicity present in diuron-treated rats was not due to urinary solids (Da Rocha et al., 2010) . Therefore, the cause of the cytotoxicity must be chemical induction by diuron itself and/or its metabolites excreted in the urine.
Diuron is considered nongenotoxic. This includes comet assays performed on the target organ, the rat urothelium. Absence of genotoxicity was observed using the standard alkaline version of the single-cell gel (comet) assay conducted with urinary bladder cells and peripheral blood leukocytes of male Wistar rats exposed through the diet for 20 weeks to different concentrations of diuron (Nascimento et al., 2006) . In addition, a modified version of the comet assay developed in vitro with Chinese hamster ovary cells indicated that diuron also does not induce DNA cross-links (Da Rocha et al., 2010) . Other mutagenicity studies also support that diuron is nongenotoxic (USEPA, 2003) .
The objective of the present studies was to evaluate the proposed MOA of diuron by determining the time course of the cytotoxic and proliferative changes induced by diuron in the urinary bladder epithelium of male Wistar rats. The evaluation was based on light microscopy, labeling index, and both SEM and transmission electron microscopy (TEM). -N,N-dimethylurea) was provided by E.I. du Pont de Nemours and Company (Wilmington, DE) . The purity of the test material as determined by Advinus Therapeutics Private Ltd. (Bangalore, India) was 98.6%. The diet concentration of 2500 ppm diuron was adjusted based on the purity. The test material was administered in Certified Purina Rodent LabDiet 5002 (PMI Nutrition International, Richmond, IN) at a concentration of 2500 ppm. The test diet was analyzed by DuPont Haskell Global Centers for Health and Environmental Sciences (Newark, DE) for homogeneity/concentration verification and stability by high-performance liquid chromatography with ultraviolet detection. Analytical results from homogeneity/ concentration verification testing of the test diet used in this study showed that diuron was homogeneously mixed into the diet at a concentration of 2500 ppm.
MATERIALS AND METHODS

Test Material
Test Animals
Wistar rats were purchased from Charles River Laboratories, Inc. (Raleigh, NC) . This is the same species and strain of animal used in the 2-year carcinogenicity study. On arrival, the animals were placed in an animal facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International and quarantined for at least 1 week before starting treatment. The study protocol was approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee and the level of care provided to the animals met or exceeded the basic requirements outlined in the Guide for Care and Use of Laboratory Animals (NIH Publication #86-23, revised 1996) . The animals were housed two per cage in polycarbonate cages with dry corn-cob bedding in a room with a targeted temperature of 22°C, humidity of 50% and a light/dark cycle of 12 h (0600 lights on/1800 lights off) and fed basal chow (Purina 5002). Diet and water were available ad libitum throughout the study.
Experiment 1
Study design. Animals were randomized into two groups (40 rats/group) using a weight stratification method (Martin et al., 1986) . Following quarantine, Group 1 continued to receive the basal chow (Purina Certified LabDiet 5002) and Group 2 was changed to Purina Certified LabDiet 5002 supplemented with 2500 ppm diuron for up to 28 days. Body weights were measured for all animals prior to randomization on study day 0. Body weights were measured on animals treated for 3 and 7 days at the end of the consumption period, which was also the day of sacrifice. Body weights for animals treated for 28 days were measured weekly. Animals were checked daily for moribundity and mortality, and more detailed clinical observations were performed prior to randomization and sacrifice. Beginning on study day 0, water consumption and diet consumption were measured over a 24-h period for animals treated for 1 day, over a 3-day period for animals treated for 3 days, and over a 7-day period for animals treated for 7 and 28 days. For the remaining treatment period, consumption was measured weekly.
All animals were terminated by an overdose of Nembutal (150 mg/kg body weight; Lundbeck, Inc., Deerfield, IL) after 1, 3, 7, or 28 days of treatment. Ten animals per group were sacrificed at each time point. One hour ± 1 min prior to sacrifice, all animals were injected ip with bromodeoxyuridine (BrdU) (100 mg/kg body weight) (Sigma Aldrich, St Louis, MO). At necropsy, the urinary bladder was inflated in situ with Bouin's fixative while the rat was under anesthesia but still alive, removed and placed in the same fixative along with a small section of the duodenum. It was essential to fix the bladder while the animal was alive because autolysis is detectable by SEM within 1 min of death (Cohen et al., 1996 (Cohen et al., , 2007 . Kidneys were removed after the bladder and duodenum, weighed and fixed in 10% buffered formalin. Following fixation, the bladders and intestinal tissue were rinsed in 70% ethanol, weighed, and observed macroscopically for abnormal findings. One half of each bladder was examined by scanning electron microscopy (SEM) and classified as described previously (Cohen et al., 1990) . Enlarged urothelial cells protruding into the lumen of the bladder were evaluated as part of the classification for cytotoxicity. Briefly, class 1 bladders have flat, polygonal superficial urothelial cells; class 2 bladders have occasional small foci of superficial urothelial cell death; class 3 bladders have numerous small foci of superficial urothelial cell death; class 4 bladders have extensive superficial urothelial cell death, especially in the dome of the bladder; and class 5 bladders have extensive cell death and piling up (hyperplasia) of rounded urothelial cells. Normal rodent urinary bladders are usually class 1 or 2, or occasionally class 3. The other half of the bladder was cut longitudinally into strips and the intestinal tissue and sections from both kidneys were embedded in paraffin. Approximately 4-5 µm sections were stained with hematoxylin and eosin (H&E) and examined histopathologically (Cohen, 1983; Cohen et al., 1990) . A diagnosis of mild simple hyperplasia was made when there were four to five cell layers in the bladder epithelium.
Unstained slides of the bladder and intestinal tissue from all animals were used for immunohistochemical detection of BrdU (Cohen et al., 2007) . The duodenal tissue served as a positive staining control and to assess the adequacy of the BrdU injection. Also, slides from three control rats and five diuron-treated rats sacrificed on study day 7 were used for immunohistochemical detection of cleaved caspase-3 for assessment of apoptosis. The duodenal tissue served as positive control. Anti-BrdU (Millipore Corporation, Temecula, CA) was used at a dilution of 1:200. Anti-cleaved caspase-3 (Asp175) (Cell Signaling Technology, Beverly, MA) was used at a dilution of 1:10. For both assays, if the duodenum showed positive staining of the mucosa, at least 3000 urothelial cells (all layers) in the urinary bladder sections were counted to determine the number of labeled cells and expressed as the percent of labeled cells to total number of cells. 
Experiment 2
Study design. The rats were randomized into two groups: Group 1 with 13 animals and Group 2 with 15 animals, using a weight stratification method (Martin et al., 1986) . Following quarantine, Group 1 continued to receive the basal chow (Purina 5002) and Group 2 was changed to Purina 5002 supplemented with 2500 ppm diuron. Body weights were measured the day after arrival, just prior to randomization, and on days 7, 35, and 42 and the day of sacrifice. Animals were checked daily for moribundity and mortality. Water consumption and diet consumption were measured over a 7-day period starting on days 0 and 35. Detailed clinical observations were performed prior to randomization and at the end of each consumption period.
After 7 days of treatment, the three animals from the control group and five animals from the 2500 ppm diuron group were terminated by an overdose of Nembutal (150 mg/kg body weight; Lundbeck, Inc.) and the bladders removed. Half of each bladder was processed for and analyzed by TEM to further evaluate the diuron-induced swelling of the urothelial cells observed by SEM in the first experiment. The urinary bladders were inflated in situ with and placed in MPG fixative (2% paraformaldehyde/2.5% glutaraldehyde in phosphate buffer) for 4 h. The bladder tissue was then longitudinally bisected. One half was processed for examination by TEM in the Electron Microscopy Laboratory (Department of Anatomic Pathology, The Nebraska Medical Center). The other half was washed in PBS after fixation and processed for examination by SEM following the procedure and classification described in the first experiment (Cohen et al., 2007) . For TEM, after bladder fixation, multiple 1 × 3 mm strips were dissected and fixed in MPG electron microscopy fixative (pH 7.38) for 2 h at 4°C. EM blocks were washed in 0.1M phosphate buffer (pH 7.4, 2 × 5 min), processed through a 6-h electron microscopy processing schedule and infiltrated with epon resin (Electron Microscopy Sciences, Fort Washington, PA) on a Leica EM TP automatic tissue processor. Tissues were embedded, oriented longitudinally and polymerized at 60°C for 24 h. Multiple 1-µm thick sections were stained with 1% toluidine blue in 1% borax and evaluated by light microscopy. Representative areas were selected, ultrasectioned at 70 nm (silver sections), and mounted on 300 mesh copper grids, double stained with Reynolds lead citrate and uranyl acetate and examined with a JEOL 1320 electron microscope.
After 8 weeks, the remaining 10 animals in each group were terminated and the bladder analyzed by light microscopy, SEM and immunohistochemical detection of BrdU as described in experiment 1. One hour ± 1 min prior to sacrifice, all animals were injected ip with BrdU (150 mg/kg body weight) (Sigma Aldrich). The necropsy, histopathology, immunohistochemical procedure, and evaluation followed the same methodology described in experiment 1. The presence of numerous swollen cells was included in the SEM analysis and classification, because it was recognized as a test substance-induced effect.
Statistics for Experiments 1 and 2
All values are reported as the mean ± SD. Group means for body and tissue weights, food and water consumption, and the BrdU and caspase labeling indices were evaluated using ANOVA, followed by Duncan's multiple range test for group-wise comparisons. Histopathology was compared using the two-tailed Fisher's Exact test. SEM data were analyzed using one-way nonparametric procedures followed by a chi-square test. P values less than 0.05 were considered significant. The statistical analyses were performed using SAS for Windows (Version 9.1).
RESULTS
Experiment 1
Clinical observation, body weight, water consumption, food consumption, and organ weight. There were no instances of animal morbidity or mortality, and none of the animals had any visible abnormalities. However, during bladder SEM evaluations, bacteria from an unknown source were observed on the bladder surface of three animals sacrificed on study day 28 (control group). The animals had no visible abnormalities during the course of the experiment, and water and food consumption and body weights were similar to other animals in the control group. SEM classification of the bladders from these animals was class 1 or 2 which is considered normal, and no abnormalities were observed during light microscopic examination of H&E slides of the bladder and kidney tissues, suggesting that the contamination occurred after the bladders were removed from the rats. However, due to the presence of the bacteria on the urothelial surface, all results for bladder and kidney histopathological diagnosis, SEM classification, and BrdU labeling index for these three animals were excluded from data analysis.
The animals treated with 2500 ppm diuron gained less weight during the experiment. Beginning on study day 7 and continuing throughout the study, the mean body weights of the 2500 ppm diuron group were significantly reduced compared with the control group (Supplementary Table 1 ). At all time points, the food consumption was decreased in the 2500 ppm diuron group compared with control. No difference in water consumption was detected (data not shown). Absolute and relative bladder weights were increased in the 2500 ppm diuron group compared with controls at all time points; however, the increase was significant only on study days 7 and 28. On study days 1 and 28, relative and absolute kidneys weights, respectively, were significantly decreased in the 2500 ppm diuron group compared with controls (Supplementary Table 2 ).
Histopathological examination of urinary bladder and kidneys. There was no significant incidence of changes in the bladder epithelium of rats treated with 2500 ppm diuron at any time point (Table 1) . There were no treatment-related changes observed in the kidneys except for changes in the papilla and medulla in one diuron-treated rat suggestive of retrograde nephropathy.
SEM examination of the bladder epithelium.
On study day 1, the SEM classification showed evidence of an effect on the epithelium due to the presence of swollen cells protruding into the lumen of three bladders (two bladders, occasional swollen cells; one bladder, numerous swollen cells) in the 2500 ppm diuron group. The presence of swollen cells was increased in the bladders from diuron-treated rats on study days 3 (6/10) and 7 (6/10) (Fig. 1) . The SEM classification was significantly different compared with control only on study day 7; however, over the time course of the study, SEM analysis showed an increase in the number and size of foci of urothelial necrosis in the 2500 ppm diuron group resulting in a gradual increase in the class of the bladder surface. On study day 28 in the diuron-treated group, there were two rats with class 4 bladders showing extensive necrosis and exfoliation and one rat with a class 5 bladder with the same necrotic changes and, in addition, piling up of round cells indicative of hyperplasia (Table 1) . These round cells showed ropy microridges and occasional uniform microvilli.
DIURON-INDUCED RAT UROTHELIAL CYTOTOXICITY
Immunohistochemical determination of BrdU and caspase labeling indices. There was no diuron-induced increase in the BrdU labeling index at any time point (Table 1) . There was no increase in the cleaved caspase-3 labeling index on study day 7 (data not shown).
Experiment 2
Clinical observation, body weight, water consumption, food consumption, and organ weight. There were no instances of animal morbidity or mortality, and none of the animals had any visible abnormalities. Similar to experiment 1, from day 7 onward the animals treated with 2500 ppm diuron gained less weight than control (p < 0.05) (Supplementary Table 3 ). Food consumption and water consumption were similar in the control and diuron-treated groups except for a significant decrease in water consumption (g/rat/day) in the diuron-treated group during week 6 (data not shown). Although terminal body weights were decreased and the relative bladder and kidneys weights were increased in diuron-treated animals compared with control group, no statistical differences were detected (Supplementary Table 4 ).
Histopathology and BrdU labeling index. After 8 weeks of treatment, there was an increased incidence of mild simple hyperplasia (6/10, p < 0.05) in the 2500 ppm diuron-treated group compared with the control group (Table 2 ). In the control and diuron-treated groups, some rats showed minimal chronic progressive nephropathy that is considered to be an age-related change not a treatment-related change. No changes in the BrdU labeling index of the urothelium were detected.
TEM at 7 days. One micrometer sections from bladders from both groups showed the typical structure of the bladder, with urothelium and underlying connective tissue and smooth muscle wall. The urothelium showed the typical distended appearance. The diuron group showed various degrees of epithelial degeneration of all layers of the urothelium up to complete loss of the epithelium, but without penetration through the basement membrane (Fig. 2) .
Ultrastructural examination of the urothelium from the control showed a normal urothelium from a distended bladder with three layers of cells (basal, intermediate, and superficial) , with normal appearance. The basal cells from this group showed normal ultrastructure: cuboidal cells with normal cytoplasmic organelles. The intermediate layer maintained a somewhat more flattened appearance, with rare apoptotic cells intertwined in the layers.
In the diuron-treated rats, there were profound ultrastructural changes of the urothelium. Minimal changes comprised distention of the cytoplasm, organelles, and nuclei characteristic of cytolysis. This resulted in enlargement of the superficial cells and protrusion of part of the superficial cells into the lumen, corresponding to the swelling of the cells observed by SEM. Occasionally, there was also loss of the luminal cytoplasmic membrane and loss of ultrastructural detail of the cytoplasmic organelles, representing severe degenerative changes and cell death. For most of the e SEM classification significantly different from 0 ppm diuron group, day 7, p < 0.05 (one-way nonparametric procedures followed by a chi-square test). f Occasional swollen prenecrotic cells present on the surface of both bladders. g Numerous swollen prenecrotic cells present on the surface of two bladders. h Results for three animals in group excluded due to the presence of bacteria observed on the urothelial surface of the bladder by SEM. i A few swollen prenecrotic cells present on the surface of two bladders. j A few swollen prenecrotic cells present on the surface of one bladder. affected area, the typical infolding of the cytoplasmic membrane was maintained, forming deep clefts and stacks of flattened plasmic membrane segments, the fusiform vesicles. However, in more severely affected areas, there was disruption to complete loss of the cell membrane on the luminal side of the superficial cell. In the most severely affected areas, there was loss of the superficial cells and occasionally loss of intermediate and basal cells. Although the basal lamina was not breached, degenerative changes comprised swelling of the underlying fibroblasts with increased intercellular spaces were identified and focally extended to the muscularis. There was no inflammatory cell infiltrate. Numerous cytoplasmic and nuclear fragments were present. For the urothelial cells that remained intact, the junctional complexes were evident although there was increased widening of the intercellular space and loss of cohesion between the cells. The nuclei in many of the surviving cells showed varying degrees of karyolysis and karyorrhexis with irregular contouring and widening of the nuclear envelope. There was loss of margination and clumping of the heterochromatin. The number of primary and secondary lysosomes was increased, particularly in the superficial cells, and some of these were greatly enlarged. Many of the urothelial cells showed varying degrees of cytolysis with loss of organelles (Fig. 2) .
SEM examination of the bladder epithelium at 7 days and 8 weeks.
On study day 7, swollen cells were present in four bladders of the treated group (two occasional and two numerous); however, none of the bladders showed extensive necrotic or proliferative changes typical of classes 4 and 5 (data not shown). Red blood cells were detected on the surface of bladders in both groups, but were considered to result from artifactual damage during necropsy. It did not affect the urinary bladder classification.
At 8 weeks, there was a significant difference in the SEM classification of bladders in the diuron-treated group compared with the control group. There were four bladders in the diuron group with extensive areas of necrosis and exfoliation (class 4) and one bladder with piling up of round cells (hyperplasia) (class 5) ( Table 2 ).
DIScUSSION
The postulated MOA for diuron-induced urinary bladder tumors in rats is cytotoxicity with prolonged, sustained, consequent regenerative proliferation, leading to urothelial The extent of cytotoxicity continues to increase after that. Although there is evidence of increased proliferation by 28 days as detected by SEM and increased BrdU labeling index (not statistically significant), we did not observe significant hyperplasia by light microscopy until 8 weeks of treatment. These observations suggest that the effect of diuron treatment on the rat bladder urothelium is relatively mild and the changes are gradual. Previous studies have shown greater degrees of necrosis and proliferation by 15 and 20 weeks of administration (Da Rocha et al., 2010; Nascimento et al., 2006) . Our results showed the presence of mild diuron-induced changes to the urothelial cells as early as study day 1, as evidenced by the presence of swollen urothelial cells. The presence of these swollen cells increased by study day 3 and persisted through study day 7. TEM analysis on study day 7 of diuron exposure showed that these swollen urothelial cells had cytoplasmic and nuclear swelling typical of degeneration, progressing to actual necrosis and cell loss in some foci. A similar phenomenon occurs in the liver and is called ballooning degeneration or oncosis (Majno and Joris, 1996) . It can progress to necrosis or it can reverse if the stimulus is removed.
TABLE 2 Effects of Dietary Administration of Diuron for 8 Weeks on the Urinary Bladder of Male Rats
In previously reported studies with diuron, swollen urothelial cells have not been observed by SEM. This is likely due to a difference in methodology. In previous studies, the urinary bladders were processed for SEM examination using osmium tetroxide fixation (Da Rocha et al., 2010) which causes the urothelial cells to contract. In the present studies, we did not use osmium for tissue processing.
Evidence of cytotoxicity occurred quickly after diuron administration began. Hyperplasia was observed as early as 7 days in the diuron-treated group by light microscopy. Somewhat surprisingly, no significant increase in BrdU labeling index was detected even though light microscopy and SEM evidence of increased cell proliferation was detected on day 28 and was significantly increased by 8 weeks.
The incidence of hyperplasia was 1 of 10 at day 7, 2 of 10 at day 28, and 6 of 10 at 8 weeks, and these were all mild in degree. The labeling index is a rate determined by the number of labeled cells divided by the total number of cells in that population. It reflects the rate of replication, not the actual number. Hyperplasia represents an increase in cell number. However, because bladder shows a low proliferative rate and hyperplasia increases the number of cells, the rate in the labeling index could decrease even with a proliferative response as observed at 28 days and 8 weeks. The main parameter is the number of DNA replications that can either be increased by decreasing the number of cell deaths or, more commonly in epithelial tissues in response to chemical toxicity, increasing the number of cell births, which could be followed by regenerative cell proliferation (Cohen, 1998) . Hyperplasia is usually accompanied by an increased proliferation rate, but not always. It could occur without an increase in the BrdU labeling index by inhibiting cell death, either by inhibiting differentiation or inhibiting apoptosis. We did not observe any changes in apoptosis. 
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Simple hyperplasia was present after treatment with diuron for 20 weeks (Nascimento et al., 2006) . The simple hyperplasia ranged from mild to severe, with greater severity observed than what was seen in the present studies of up to 8 weeks in duration. Cell proliferation was present in these longer studies as evidenced by an increase in the PCNA labeling index. However, expression of PCNA increases during phase G1, peaks in phase S, and declines during phases G2 and M, whereas BrdU is incorporated into nuclei during the S phase of the cell cycle. Diuron is a relatively weak carcinogen. The mild cytotoxicity and proliferation observed after high doses at early exposure times appeared to increase over time when the high level of exposure was sustained. This continued exposure maintains cytotoxicity and a compensatory proliferative response, which could eventually lead to tumor development. Gene expression changes observed at 7 days (Ihlaseh et al., unpublished data) and 20 weeks (Ihlaseh et al., 2011) of diuron dietary exposure showed significant differences, suggesting an initial adaptive response to protect the urothelium from the diuron toxicity that is overcome with long-term exposure (Ihlaseh et al., 2011) .
Increased proliferation of the urothelium occurs either due to direct mitogenesis, with only one known example (propoxur) (Cohen et al., 1994) , or more commonly due to increased cell deaths and regeneration (Cohen, 1998) . Increased cell death is usually due to necrosis. Regenerative proliferation ensues which is dependent for its continuance on sustained exposure to the inciting stimulus.
Cytotoxicity and necrosis of the urothelium can be caused by urinary solids, cytotoxic chemicals (parent compound and/or a metabolite), or extremes of urinary composition, such as pH > 9 (Cohen, 1998) . It has previously been shown that diuron does not induce a change in urinary pH, and urinary solids do not play a role in the rat urinary bladder carcinogenesis induced by high dietary concentrations of diuron. Thus, cytotoxicity appears to be chemically induced by diuron and/or its metabolites (Da Rocha et al., 2010) . Urinary bladder gene expression analysis of diuron-treated Wistar rats suggested that persistent exposure to high dietary concentrations of diuron induced oxidative stress, increased cellular metabolism, and enhanced cell death associated with sustained urothelial hyperplasia (Ihlaseh et al., 2011) .
Although the specific mechanism leading to diuroninduced necrosis is unclear, our results strongly suggest that the MOA of diuron-induced rat bladder carcinogenesis starts with urothelial cell degeneration evidenced by the presence of the swollen urothelial cells. Continued exposure to diuron resulted in necrosis and exfoliation detected by SEM and TEM, with consequent cell proliferation evidenced by hyperplasia at 8 weeks as detected by SEM and light microscopy. These data suggest that cytotoxicity followed by regenerative cell proliferation are the sequential key events of diuron-induced urothelial carcinogenesis in the urinary bladder epithelium that occur after long-term high-diuron exposure in rats.
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